Mucosal Healing and Clinical remission after Treatment with Adalimumab in Small Intestinal Crohn's Disease (SIMCHA study): final results from a prospective, open-label, single-arm study

被引：0
|
作者：
Wetwittayakhlang, P. [1 ]
Golovics, P. [1 ]
Hahn, G. [1 ]
Bessissow, T. [1 ]
Afif, W. [1 ]
Wild, G. [1 ]
Bitton, A. [1 ]
Lakatos, P. L. [1 ]
机构：
[1] McGill Univ, IBD Ctr, Hlth Ctr, Montreal, PQ, Canada
来源：
JOURNAL OF CROHNS & COLITIS | 2022年 / 16卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P321
引用
收藏
页码：I343 / I344
页数：3
相关论文
共 50 条
  • [41] Efficacy and safety of Privigen® in patients with chronic inflammatory demyelinating polyneuropathy: results of a prospective, single-arm, open-label Phase III study (the PRIMA study)
    Leger, Jean-Marc
    De Bleecker, Jan L.
    Sommer, Claudia
    Robberecht, Wim
    Saarela, Mika
    Kamienowski, Jerzy
    Stelmasiak, Zbigniew
    Mielke, Orell
    Tackenberg, Bjoern
    Shebl, Amgad
    Bauhofer, Artur
    Zenker, Othmar
    Merkies, Ingemar S. J.
    JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, 2013, 18 (02) : 130 - 140
  • [42] Adalimumab Therapy maintains steroid-free remission and Fistula Closure in patients with moderate to severe Crohn's Disease Results of an Open-Label Study in Canada (ACCESS)
    Panaccione, R.
    Loftus, E., Jr.
    Binion, D.
    McHugh, K.
    Chen, N.
    Chao, J.
    Mulani, P.
    INFLAMMATORY BOWEL DISEASES, 2009, 15 (12) : S43 - S43
  • [43] Abatacept in IgG4-related disease: a prospective, open-label, single-arm, single-centre, proof-of-concept study
    Matza, Mark A.
    Perugino, Cory A.
    Harvey, Liam
    Fernandes, Ana D.
    Wallace, Zachary S.
    Liu, Hang
    Allard-Chamard, Hugues
    Pillai, Shiv
    Stone, John H.
    LANCET RHEUMATOLOGY, 2022, 4 (02): : E105 - E112
  • [44] Long-term safety and efficacy of risankizumab treatment in patients with Crohn's disease: Final results from the Phase 2 open-label extension study
    Ferrante, M.
    Feagan, B. G.
    Panes, J.
    Baert, F.
    Louis, E.
    Dewit, O.
    Kaser, A.
    Duan, W. R.
    Gustafson, D.
    Liao, X.
    Wallace, K.
    Kalabic, J.
    D'Haens, G. R.
    JOURNAL OF CROHNS & COLITIS, 2020, 14 : S024 - S025
  • [45] LONG-TERM SAFETY AND EFFICACY OF RISANKIZUMAB TREATMENT IN PATIENTS WITH CROHN'S DISEASE: FINAL RESULTS FROM THE PHASE 2 OPEN-LABEL EXTENSION STUDY
    Ferrante, Marc
    Feagan, Brian G.
    Panes, Julian
    Baert, Filip J.
    Louis, Edouard
    Dewit, Olivier
    Kaser, Arthur
    Duan, Weijiang
    Gustafson, Dawn
    Liao, Xiaomei
    Wallace, Kori
    Kalabic, Jasmina
    D'Haens, Geert R.
    GASTROENTEROLOGY, 2020, 158 (06) : S1198 - S1198
  • [46] Efficacy and safety of pantoprazole and itopride in patients with overlap of gastroesophageal reflux disease and dyspepsia: A prospective, open-label, single-arm pilot study
    Lakhtakia, Sundeep
    Singh, Aniruddha P.
    Singla, Neeraj
    Memon, Sana F.
    Reddy, Duvvur N.
    JGH OPEN, 2024, 8 (02):
  • [47] Effect of robot-assisted gait training on gait automaticity in Parkinson disease A prospective, open-label, single-arm, pilot study
    Yun, Seo Jung
    Lee, Hyun Haeng
    Lee, Woo Hyung
    Lee, Seung Hak
    Oh, Byung-Mo
    Seo, Han Gil
    MEDICINE, 2021, 100 (05) : E24348
  • [48] Paricalcitol Treatment of Secondary Hyperparathyroidism in Hemodialysis Patients: A German-Austrian, Single-Arm, Open-Label, Prospective, Noninterventional, Observational Study
    Biggar, Patrick
    Kovarik, Josef
    Klauser-Braun, Renate
    Graf, Helmut
    Mueller, Hans-Walter
    Veres, Andras
    Seidinger, Susanne
    Ketteler, Markus
    NEPHRON CLINICAL PRACTICE, 2014, 126 (01): : 39 - 50
  • [49] INFLIXIMAB THERAPY FOR NEUROLOGICAL, VASCULAR, AND INTESTINAL INVOLVEMENT IN BEHCET'S DISEASE: EFFICACY, SAFETY, AND PHARMACOKINETICS IN A MULTI-CENTER, PROSPECTIVE, OPEN-LABEL, SINGLE-ARM PHASE 3 STUDY
    Ishigatsubo, Y.
    Hirohata, S.
    Kikuchi, H.
    Tateishi, U.
    Sato, N.
    Ozaki, K.
    Kondo, K.
    Hibi, T.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2016, 34 (06) : S148 - S149
  • [50] The OASIS (OpicApone in Sleep dISorder) study in Parkinson's disease: design and rationale of an open-label, single-arm, pilot trial
    Costa, R.
    Trenkwalder, C.
    Ferreira, J.
    Magalhaes, D.
    Rocha, J.
    Soares-da-Silva, P.
    MOVEMENT DISORDERS, 2021, 36 : S167 - S167
12345